Product Information

TICAGRELOR 90 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.2634 per EA under NDC 50228052260. Its NADAC has been published 33 times since Jan 7, 2026.

FDA first approved this application on Oct 28, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TICAGRELOR 90 MG TABLET

ticagrelor
$0.2634per EA

Strength

90 mg/1

NDC

50228052260

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TICAGRELOR

Approval Type

Generic (ANDA)

FDA Application

ANDA218962

FDA Approved

10/28/2025

TE Code

AB

On Market Since

10/9/2025

Pharmacological Classes

Cytochrome P450 3A4 Inhibitors
Decreased Platelet Aggregation
P-Glycoprotein Inhibitors
P2Y12 Platelet Inhibitor
P2Y12 Receptor Antagonists

Price Statistics

The NADAC for TICAGRELOR 90 MG TABLET has been published 33 times since Jan 7, 2026, and over the history we have for it it has declined 42.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2634 per EA
All-time high$0.4577 (Jan 14, 2026)
All-time low$0.2634 (Aug 19, 2026)
52-week high$0.4577
52-week low$0.2634
Median price$0.2978
Average price$0.3280
Largest weekly change-13.1% (Feb 18, 2026)
Weeks tracked33
Tracking sinceJan 7, 2026

Price History

1W

-5.8%

1M

-5.8%

3M

-9.5%

6M

-28.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

-42.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ticagrelor market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of TICAGRELOR 90 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TICAGRELOR 90 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.2634 per EA (NDC 50228052260), effective Aug 19, 2026.

How has the price of TICAGRELOR 90 MG TABLET changed over time?

Over the history we have for it, the NADAC for TICAGRELOR 90 MG TABLET has declined 42.4%. It has been tracked across 33 weekly CMS publications since Jan 7, 2026.

What are the highest and lowest recorded NADAC prices for TICAGRELOR 90 MG TABLET?

Since Jan 7, 2026, the NADAC for TICAGRELOR 90 MG TABLET has ranged from a low of $0.2634 (Aug 19, 2026) to a high of $0.4577 (Jan 14, 2026), with a median of $0.2978 per EA.

Are there cheaper alternatives to TICAGRELOR 90 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of TICAGRELOR 90 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TICAGRELOR 90 MG TABLET?

TICAGRELOR 90 MG TABLET (NDC 50228052260) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.